These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6539956)

  • 41. The effect of indomethacin, 6-hydroxydopamine, saralasin, and hemorrhage on renal hemodynamics.
    Fischer R; Ikeda S; Sarma JS; Bing RJ
    J Clin Pharmacol; 1977 Jan; 17(1):5-12. PubMed ID: 833339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conjugate effects of saralasin and indomethacin on kidney function in anesthetized dog.
    Tost H; Kövér G; Darvasi A
    Acta Physiol Hung; 1995; 83(1):63-77. PubMed ID: 7660839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II and alpha-adrenergic control of the intrarenal circulation in hemorrhage.
    Hock CE; Passmore JC; Levin JI; Neiberger RE
    Circ Shock; 1982; 9(1):81-94. PubMed ID: 6279332
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local renal ischemia during burn shock in rat effected by thromboxane A2 and serotonin.
    Haugan A; Kirkebø A
    Circ Shock; 1986; 20(1):13-23. PubMed ID: 3021355
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison between vascular plasminogen activator activity and changes in blood flow in the renal cortex in pigs.
    Smokovitis A; Maier M; Binder BR
    Thromb Haemost; 1984 Apr; 51(2):150-3. PubMed ID: 6539956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.